Medtronic: Coronary Artery Disease trials

The registry lists 47 Coronary Artery Disease studies with Medtronic as lead sponsor. 2 are open to participants now and 22 have results posted.

Phase 1 1Phase 2 1Phase 3 1Phase 4 5No phase 40(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Prevail Global StudyRecruitingNCT06535854Not applicable
• Product Surveillance RegistryRecruitingNCT01524276
• A Single Arm Trial With Resolute Onyx in ONE-Month DAPT for High-Bleeding Risk Patients Who Are Considered One-Month Clear (Onyx ONE Clear)CompletedNCT03647475Not applicableResults posted
• RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort)CompletedNCT03584464Not applicableResults posted
• Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical StudyCompletedNCT02419521Not applicableResults posted
• Medtronic Resolute Onyx 2.0 mm Clinical StudyCompletedNCT02412501Not applicableResults posted
• Resolute Integrity US Extended Length Sub-Study(RI US XL)CompletedNCT01913600Not applicableResults posted
• An Evaluation of the Commercially Available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent SystemCompletedNCT01638507Not applicableResults posted
• DELIVER Study: DELiverability of the Resolute Integrity Stent in All-Comer Vessels and Cross-OvER StentingCompletedNCT01297257Results posted
• On Versus Off Pump Myocardial Revascularization StudyCompletedNCT01290952Phase 4Results posted
• RESOLUTE Japan SVS: The Clinical Evaluation of the MDT-4107 DES in the Treatment of De Novo Lesions in Small Diameter Native Coronary ArteriesCompletedNCT01150500Not applicableResults posted
• EDUCATE: The MEDTRONIC Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic EventsCompletedNCT01069003Phase 4Results posted
• Tri Staple Technology Stapler Used in Gastric BypassCompletedNCT01026103Not applicableResults posted
• Sprinter Legend Balloon CatheterCompletedNCT00961311Not applicableResults posted
• ST Segment Detection StudyTerminatedNCT00930969Results posted
• RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary StentCompletedNCT00927940Not applicableResults posted
• PROTECT Continued Access Post Marketing Surveillance TrialCompletedNCT00846846Phase 4Results posted
• RESOLUTE International Registry: Evaluation of the Resolute Zotarolimus-Eluting Stent System in a 'Real-World' Patient PopulationCompletedNCT00752128Results posted
• The Medtronic RESOLUTE US Clinical TrialCompletedNCT00726453Not applicableResults posted
• E-Five Registry: A World-Wide Registry With The Endeavor Zotarolimus Eluting Coronary StentCompletedNCT00623441Results posted
• Randomized, Two-arm, Non-inferiority Study Comparing Endeavor-Resolute Stent With Abbot Xience-V StentCompletedNCT00617084Phase 4Results posted
• Endeavor Zotarolimus - Eluting Stent in the Treatment Lesions in Small Native Coronary Arteries.CompletedNCT00609947Not applicableResults posted
• Bare Metal Bifurcation Stent Clinical Trial in HumansCompletedNCT00607321Not applicableResults posted
• Randomized Study Comparing Endeavor With Cypher Stents (PROTECT)CompletedNCT00476957Phase 4Results posted
• Advancing Cath Lab Results With FFRangio Coronary Physiology AssessmentActive, not recruitingNCT05893498Not applicable
• RESOLUTE ONYX China Single Arm StudyCompletedNCT03471845Not applicable
• RESOLUTE ONYX China RCT StudyCompletedNCT03466151Not applicable
• Angiogram Based Fractional Flow Reserve in Patients With Multi-Vessel DiseaseCompletedNCT03455244
• A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk PatientsCompletedNCT03344653Not applicable
• The PREVAIL StudyCompletedNCT03260517Not applicable
• FFRangio Accuracy vs. Standard FFRCompletedNCT03226262
• China Resolute Integrity 34/38 mm StudyCompletedNCT03118531Not applicable
• RESOLUTE ONYX Post-Approval StudyCompletedNCT03063749
• Angiogram Based Fractional Flow Reserve FFRangio - A Validation StudyCompletedNCT03005028
• Medtronic RevElution TrialCompletedNCT02480348Not applicable
• Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY)CompletedNCT02452736Phase 3
• RESOLUTE China RCTCompletedNCT01334268Not applicable
• RESOLUTE China Registry:CompletedNCT01243749
• RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in AsiaCompletedNCT01132456Not applicable
• Assessment of Clinical Performance and Costs of the Endeavor Resolute Stent "in Real Life" in Spain.CompletedNCT00850213
• China Endeavor Registry: A Registry With The Endeavor Zotarolimus Eluting Coronary Stent in ChinaCompletedNCT00793312
• The ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery LesionsCompletedNCT00614848Not applicable
• The ENDEAVOR Pharmacokinetic (PK) Registry: The Medtronic Endeavor Drug Eluting Coronary Stent SystemCompletedNCT00314275Not applicable
• The Medtronic RESOLUTE Clinical TrialCompletedNCT00248079Phase 1/2
• The ENDEAVOR IV Clinical Trial: A Trial of a Coronary Stent System in Coronary Artery LesionsCompletedNCT00217269Not applicable
• The Medtronic Endeavor III Drug Eluting Coronary Stent System Clinical TrialCompletedNCT00217256Not applicable
• Clinical and Economic Consequences of Left Atrial Bipolar Radiofrequency Ablation of Persistent and Permanent Atrial Fibrillation During Cardiac SurgeryTerminatedNCT00157807Not applicable